![]() |
Volumn 10, Issue 6, 2012, Pages 660-662
|
Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYOTROPHIC LATERAL SCLEROSIS;
CENTRAL NERVOUS SYSTEM DISEASE;
CORPUS STRIATUM;
COST EFFECTIVENESS ANALYSIS;
DENERVATION;
DOPAMINERGIC NERVE CELL;
DOPAMINERGIC SYSTEM;
EMBRYONIC STEM CELL;
HUMAN;
HUNTINGTON CHOREA;
MEDICAL RESEARCH;
MOTONEURON;
NIGRONEOSTRIATAL SYSTEM;
NONHUMAN;
PARKINSON DISEASE;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
PYRAMIDAL TRACT;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
STEM CELL TRANSPLANTATION;
SUBSTANTIA NIGRA;
TREATMENT INDICATION;
TREATMENT OUTCOME;
|
EID: 84862524308
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2012.04.004 Document Type: Note |
Times cited : (15)
|
References (9)
|